Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Tinnitus
NCT00257270Phase 2Completed
- Sponsor
- Tinnitus Research Consortium
- Start
- Aug 2003
- Modality
- Small Molecules
01
Overview
Phase 2, single-blind trial of gabapentin in tinnitus (2 arms), sponsored by Tinnitus Research Consortium. Primary endpoints: Psychophysical loudness match of tinnitus to broad band noise and pure tones and Tinnitus Handicap Questionnaire Score. Started Aug 2003; status: completed.
02
Drugs
gabapentin
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT00257270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257270.